188Re- and 99mTc-MAG3 as prosthetic groups for labeling amines and peptides:: Approaches with pre- and postconjugate labeling

被引:60
作者
Guhlke, S
Schaffland, A
Zamora, PO
Sartor, J
Diekmann, D
Bender, H
Knapp, FF
Biersack, HJ
机构
[1] Univ Bonn, Klin Nukl Med, D-53127 Bonn, Germany
[2] Rho Med Inc, Albuquerque, NM USA
[3] Oak Ridge Natl Lab, Oak Ridge, TN USA
关键词
rhenium-188; technetium-99m; MAG(3) peptides; RC-160; MAG(3)-RC-160; somatostatin;
D O I
10.1016/S0969-8051(98)00025-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Either radiolabeled Tc-99m or Re-188-labeled MAG(3)-4 -nitrophenylester or unlabeled Bz-MAG(3)-4-nitrophenylester was reacted with amines and peptides to follow a pre- or a postconjugate radiolabeling route, respectively. The model compounds were N'-t-butyloxycarbonyl-1,6-diaminohexane (DH-Boc) and a Lys-protected derivative of the somatostatin analog RC-160 (cyclic D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2). In the case of labeling DH-Boc, both the preconjugate labeling and the postconjugate labeling were found by using analytical HPLC to provide identical radiolabeled compounds regardless whether Re-188 or Tc-99m was used. The results are supported by infrared and mass-spectral data obtained from compounds synthesized using stable rhenium, The Re-188- or Tc-99m-MAG(3)-RC-160 somatostatin analog were synthesized following the preconjugate labeling route and subsequent removal of the protecting group. Biodistributions of Re-188, and Tc-99m-MAG(3)-RC-160 were evaluated in normal and tumor bearing mice, and were similar to those of radioiodinated I-131-RC-160. All radiolabeled analogs of RC-160 were rapidly cleared from the blood and were excreted through the hepatobiliary system with very little normal organ uptake. The tumor uptake (PC-3, human prostate adenocarcinoma) of systemically administered Re-188-MAG(3)-RC160 was very low, and it reached only 0.28% injected dose/g (%IDg) at 24 h postinjection, similar to what was obtained with I-131-RC-160. Intratumor injections resulted in significant tumor retentions (9.3% ID/g at 24 h), NUCL (C) 1998 Elsevier Science Inc.
引用
收藏
页码:621 / 631
页数:11
相关论文
共 35 条
  • [1] BABICH JW, 1993, J NUCL MED, V34, P2176
  • [2] A NEW RADIOLABELED SOMATOSTATIN ANALOG [IN-111-DTPA-D-PHE(1)]RC-160 - PREPARATION, BIOLOGICAL-ACTIVITY, RECEPTOR SCINTIGRAPHY IN RATS AND COMPARISON WITH [IN-111-DTPA-D-PHE(1)]OCTREOTIDE
    BREEMAN, WAP
    HOFLAND, LJ
    VANDERPLUIJM, M
    VANKOETSVELD, PM
    DEJONG, M
    SETYONOHAN, B
    BAKKER, WH
    KWEKKEBOOM, DJ
    VISSER, TJ
    LAMBERTS, SWJ
    KRENNING, EP
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1994, 21 (04): : 328 - 335
  • [3] RADIOIODINATED SOMATOSTATIN ANALOG RC-160 - PREPARATION, BIOLOGICAL-ACTIVITY, IN-VIVO APPLICATION IN RATS AND COMPARISON WITH [I-123-TYR(3)]OCTREOTIDE
    BREEMAN, WAP
    HOFLAND, LJ
    BAKKER, WH
    VANDERPLUIJM, M
    VANKOETSVELD, PM
    DEJONG, M
    SETYONOHAN, B
    KWEKKEBOOM, DJ
    VISSER, TJ
    LAMBERTS, SWJ
    KRENNING, EP
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1993, 20 (11): : 1089 - 1094
  • [4] EVALUATION IN-VITRO AND IN RATS OF TB-161-DTPA-OCTREOTIDE, A SOMATOSTATIN ANALOG WITH POTENTIAL FOR INTRAOPERATIVE SCANNING AND RADIOTHERAPY
    DEJONG, M
    BREEMAN, WAP
    BERNARD, BF
    ROLLEMAN, EJ
    HOFLAND, LJ
    VISSER, TJ
    SETYONOHAN, B
    BAKKER, WH
    VANDERPLUIJM, ME
    KRENNING, EP
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1995, 22 (07): : 608 - 616
  • [5] THE CHEMISTRY OF RHENIUM AND TECHNETIUM AS RELATED TO THE USE OF ISOTOPES OF THESE ELEMENTS IN THERAPEUTIC AND DIAGNOSTIC NUCLEAR-MEDICINE
    DEUTSCH, E
    LIBSON, K
    VANDERHEYDEN, JL
    KETRING, AR
    MAXON, HR
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1986, 13 (04): : 465 - 477
  • [6] FISCHMAN AJ, 1993, J NUCL MED, V34, P2130
  • [7] FRITZBERG AR, 1986, J NUCL MED, V27, P111
  • [8] FLUOROACYLATION AGENTS BASED ON SMALL NCA [F-18] FLUOROCARBOXYLIC ACIDS
    GUHLKE, S
    COENEN, HH
    STOCKLIN, G
    [J]. APPLIED RADIATION AND ISOTOPES, 1994, 45 (06) : 715 - 727
  • [9] (2-[F-18]FLUOROPROPIONYL-(D)PHE(1))-OCTREOTIDE, A POTENTIAL RADIOPHARMACEUTICAL FOR QUANTITATIVE SOMATOSTATIN RECEPTOR IMAGING WITH PET - SYNTHESIS, RADIOLABELING, IN-VITRO VALIDATION AND BIODISTRIBUTION IN MICE
    GUHLKE, S
    WESTER, HJ
    BRUNS, C
    STOCKLIN, G
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1994, 21 (06) : 819 - 825
  • [10] GUHLKE S, 1995, TECHNETIUM RHENIUM C, V4, P363